Physician profile
Celia Mendes
NPI 1952411498
$1,965.85
in general payments reported to CMS, 2019-2025
20 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,192 · 2020: $246 · 2021: $253 · 2022: $56.05 · 2023: $81.94 · 2024: $14.67 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $218.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $821.23 | 2019-2021 | |
| Abbvie INC. | $477.48 | 2019-2023 | |
| Therapeuticsmd, INC. | $94.96 | 2019-2021 | |
| Novo Nordisk INC | $80.66 | 2019-2023 | Saxenda, Wegovy |
| Hologic Sales and Service, LLC | $78.56 | 2019-2025 | Thinprep 2000 Processor, Aptima, Affirm Prone Biopsy System |
| Sumitomo Pharma America, INC. | $63.83 | 2025 | Gemtesa |
| Lupin INC. | $52.78 | 2019-2021 | |
| Galderma Laboratories, L.P. | $44.12 | 2019-2021 | |
| Pfizer INC. | $43.92 | 2019-2022 | |
| Lilly USA, LLC | $31.70 | 2024-2025 | Zepbound, Jardiance |
| Daiichi Sankyo INC. | $31.51 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $29.25 | 2019 | |
| Organon LLC | $17.36 | 2021 | |
| Boston Scientific Corporation | $17.14 | 2021 | |
| Astellas Pharma US INC | $15.76 | 2025 | Veozah |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15.74 | 2019 | |
| Radius Health, INC. | $13.70 | 2019 | |
| Eisai INC. | $12.67 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.00 | 2019 | |
| Avion Pharmaceuticals | $11.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Celia Mendes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.